Skip to main content
MGTX
NASDAQ Life Sciences

MeiraGTx Repurchases $18.2M in Shares from Perceptive Master Fund, Securing 12-Month Lock-Up

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.95
Mkt Cap
$639.903M
52W Low
$4.55
52W High
$9.73
52W Position info
75% above low
Off High info
18% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

MGTX sits 75% above its 52-week low of $4.55.

Summary

MeiraGTx Holdings plc executed an $18.2 million share repurchase from Perceptive Life Sciences Master Fund, a significant capital allocation that also includes a 12-month lock-up on Perceptive's remaining shares.


Key Events · Financing and Capital Events · MGTX

  • Significant Share Repurchase

    MeiraGTx repurchased 2,300,000 ordinary shares for $18.193 million at $7.91 per share.

  • Major Investor Sale for Tax Optimization

    Perceptive Life Sciences Master Fund, a major institutional investor and >10% owner, sold shares citing year-end portfolio tax optimization activities, rather than fundamental concerns about the company.

  • 12-Month Lock-Up Agreement

    Perceptive and its affiliates agreed to a 12-month lock-up period, restricting the sale or transfer of their remaining substantial shareholdings.

  • Debt Holder Consent Secured

    Perceptive Credit Holdings III, LP, a significant noteholder and affiliate of the selling shareholder, provided consent for the repurchase, waiving any potential default under the existing Notes Purchase Agreement.


Analysis · MGTX · Life Sciences

The company's significant share repurchase demonstrates a commitment to enhancing shareholder value by reducing the outstanding share count. The transaction, priced at the volume-weighted average price, involved a major institutional investor, Perceptive Life Sciences Master Fund, which cited year-end tax optimization as the reason for its sale, mitigating concerns about a loss of confidence. Furthermore, Perceptive's agreement to a 12-month lock-up on its remaining substantial holdings signals continued long-term commitment. This move also required and received consent from Perceptive Credit Holdings III, a key debt holder, ensuring the repurchase aligns with existing financial agreements.

At the time of this filing, MGTX was trading at $7.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $639.9M. The 52-week trading range was $4.55 to $9.73. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGTX - Latest Insights

MGTX
Jul 07, 2026, 7:42 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $14.42
Real-time Price: $11.79 info
Change: -$2.63 (-18%) info
Market Cap: $1.092B info
MGTX
Jul 07, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $14.65
Real-time Price: $11.79 info
Change: -$2.86 (-20%) info
Market Cap: $1.092B info
MGTX
May 14, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $9.70
Real-time Price: $11.79 info
Change: +$2.09 (+22%) info
Market Cap: $1.092B info
MGTX
May 14, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.70
Real-time Price: $11.79 info
Change: +$2.09 (+22%) info
Market Cap: $1.092B info
MGTX
Apr 30, 2026, 8:04 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.78
Real-time Price: $11.79 info
Change: +$3.01 (+34%) info
Market Cap: $1.092B info